FIELD: medicine.
SUBSTANCE: method involves applying means for fluidizing vitreous body. The means has urease or urease derivatives.
EFFECT: enhanced effectiveness of treatment.
24 cl
| Title |
Year |
Author |
Number |
| AGENTS FOR APPLICATION INTO EYE CORNEA OR STROMA FOR TREATMENT OF PREVENTION OF OPHTHALMOLOGICAL DISORDERS |
2003 |
- Karageozjan Vikken
- Kastilledzhos David
- Park Dzhon
- Aragon Gabriehl' Arturo Karpio
- Flores Khose Luis Gut'Erres
|
RU2363459C2 |
| TRATMENT FOR OCULAR DISORDERS, USING UREA AND ITS DERIVATIVES |
2003 |
- Karageozjan Vikken
- Kastilledzhos David
- Park Dzhon
|
RU2339369C2 |
| INTEGRIN RECEPTOR ANTAGONISTS AND USE THEREOF |
2012 |
- Mackel Michael John
- Park John Y.
- Karageozian Hampar L.
- Karageozian Vicken H.
|
RU2721907C2 |
| COMPOSITIONS AND METHODS FOR INHIBITION OF CELLULAR ADHESION OR DIRECTION OF DIAGNOSTIC OR THERAPEUTIC AGENTS TO RGD BINDING SITES |
2010 |
- Mackel Michael John
- Park John
|
RU2642625C2 |
| COMPOSITIONS AND METHODS FOR ANGIOGENESIS SUPPRESSION |
2010 |
- Mekel Majkl Dzhon
- Park Dzhon
|
RU2786127C2 |
| PREVENTIVE AND THERAPEUTIC AGENT FOR POSTERIOR EYE DISEASES |
2008 |
- Okamoto Kazuesi
- Sibagaki Keiiti
|
RU2470635C2 |
| COMPOSITIONS AND METHODS FOR INSERTION OF TUBULIN-BINDING AGENTS FOR EYE DISEASE THERAPY |
2002 |
|
RU2354398C2 |
| COMPOSITIONS AND WAYS OF INJECTIONS OF AGENTS BINDING TUBULIN, FOR TREATMENT OF EYE DISEASES |
2004 |
|
RU2359693C2 |
| METHOD OF TREATING OPHTHALMIC ANGIOGENESIS, RETINAL OEDEMA, RETINAL ISCHEMIA AND DIABETIC RETINOPATHY WITH USING SELECTIVE RTK INHIBITORS |
2006 |
|
RU2445096C2 |
| TREATMENT OF EYE DISEASES SUCH AS MACULAR DEGENERATION, GLAUCOMA AND DIABETIC RETINOPATHY WITH MEDICATIONS THAT ELIMINATE AGING CELLS |
2018 |
- Hopkins, Jill
- Tsuruda, Pam
- Chapman, Claude
- Sweigard, Harry
- Poon, Yan
- Marquess, Daniel
- David, Nathaniel
- Dananberg, Jamie
- Laberge, Remi-Martin
|
RU2815482C2 |
